Company intelligence / Profile preview

Trudell Medical

London, Ontario, Canada

Ownership: Private
Employees: ~787
Development stage: Other

Overview

Trudell Medical is a leading global developer and manufacturer of respiratory drug delivery and lung health devices, primarily focused on asthma, COPD, cystic fibrosis, and bronchiectasis. Its products help optimize medication delivery and airway clearance for patients with chronic respiratory conditions. The company is expanding into respiratory diagnostics and has a broad portfolio of commercialized devices used in hospitals and at home[4][5][6].

Therapeutic areas: Pulmonology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Vyaire Medical (distribution, formerly; acquisition in progress)Pharmaceutical partners (for drug delivery devices, not explicitly named)

Beyond the preview

Go deeper on Trudell Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trudell Medical.

Explore the full profile